Methylenedioxymethamphetamine (MDMA), often sold as ‘Ecstasy’ or ‘Molly’, is commonly
used at music festivals and reported to be responsible for an increase in deaths over the last …

Background Antidepressant response to a single subanesthetic dose infusion of the
glutamatergic modulator ketamine is transient in most depressed patients; however, a minority …

To the Editor: da Frota Ribeiro et al.(2016) reported successful treatment of two cases of
psychotic depression with intravenous ketamine. Ketamine administration lessened both …

Rationale Ketamine is a novel, rapid-acting antidepressant for treatment refractory depression
(TRD); however, clinical durability is poor and treatment response trajectories vary. Little …

Attention-deficit/hyperactivity disorder (ADHD) is associated with increased risk of detrimental
life outcomes. Recent research also indicates that ADHD is associated with sexual risk …

Over the past two decades, antibiotic resistance has become a major clinical and public
health problem. The requirement that conventional antibiotics be used at high concentrations …

Objective: A systematic review was conducted of the biomedical literature regarding pastoral
care (PaC) providers on inpatient psychiatric units with the aim of answering 3 questions:(1) …

Background Although ketamine has been shown to produce a rapid antidepressant effect,
little has been reported regarding ketamine’s effects on subtypes of depression. Atypical …

Background Ketamine is a rapid-acting, poor durability, treatment for patients with treatment
refractory depression (TRD). Little is known about which patient characteristics are …

… In particular I would like to thank Steven Pennybaker for his contributions, which far exceed
those of a typical undergraduate researcher, and also Nancy Hopkins, Adam Amsterdam, …